secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2026-02-17T23:59:59+00:00
Accession:  0001104659-26-016378
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus Oncology closes $47M public offering of 28.6M shares at $1.75/share
---------------------------------------------------------------------------

- Issued 28.6M common shares at $1.75 public price; underwriters paid $1.645/share.
- Net proceeds of ~$47.0M after underwriting discounts and commissions.
- Underwriters have 30-day option to purchase up to 4.29M additional shares for over-allotments.
- Directors, officers, and certain stockholders subject to 60-day lock-up agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000110465926016378/0001104659-26-016378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000110465926016378/chrs-20260212x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-016378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer